Related references
Note: Only part of the references are listed.Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance
Hannah Abacka et al.
HAEMATOLOGICA (2021)
Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment
Tai-Hua Tsai et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Functional Expression of the Human Glucose Transporters GLUT2 and GLUT3 in Yeast Offers Novel Screening Systems for GLUT-Targeting Drugs
Sina Schmidl et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Identification of new GLUT2-selective inhibitors through in silico ligand screening and validation in eukaryotic expression systems
Sina Schmidl et al.
SCIENTIFIC REPORTS (2021)
Glucose Transporters as a Target for Anticancer Therapy
Monika Pliszka et al.
CANCERS (2021)
A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1
Catherine J. Libby et al.
CELL ADHESION & MIGRATION (2021)
Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells
Kalpana Tilekar et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth
Caroline Contat et al.
ELIFE (2020)
Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer
Kalpana Tilekar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Glucose transporters in brain in health and disease
Hermann Koepsell
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2020)
Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential
Kalpana Tilekar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Fanconi-Bickel Syndrome: A Review of the Mechanisms That Lead to Dysglycaemia
Sanaa Sharari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
GLUT3 induced by AMPK/CREB1 axis is key for withstanding energy stress and augments the efficacy of current colorectal cancer therapies
Weixing Dai et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Glucose Transporter-1 (GLUT-1) Expression is Associated with Tumor Size and Poor Prognosis in Locally Advanced Gastric Cancer
Chenqing Yin et al.
MEDICAL SCIENCE MONITOR BASIC RESEARCH (2020)
The glucose transporter type 1 (Glut1) syndromes
Henner Koch et al.
EPILEPSY & BEHAVIOR (2019)
The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis
Bo Zhang et al.
GENE (2019)
Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy
Angara Zambrano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
GLUT1 regulates cell glycolysis and proliferation in prostate cancer
Hengjun Xiao et al.
PROSTATE (2018)
Identification of Compounds That Decrease Glioblastoma Growth and Glucose Uptake in Vitro
Catherine J. Libby et al.
ACS CHEMICAL BIOLOGY (2018)
Evidence for brain glucose dysregulation in Alzheimer's disease
Yang An et al.
ALZHEIMERS & DEMENTIA (2018)
The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma
Damien Ambrosetti et al.
PLOS ONE (2018)
Ligand Screening Systems for Human Glucose Transporters as Tools in Drug Discovery
Sina Schmidl et al.
FRONTIERS IN CHEMISTRY (2018)
Clinicopathological and prognostic significance of GLUT1 in breast cancer A meta-analysis
Yu Deng et al.
MEDICINE (2018)
Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival
Hans Anton Schloesser et al.
GASTRIC CANCER (2017)
Role of glucose metabolism related gene GLUT1 in the occurrence and prognosis of colorectal cancer
Wenming Feng et al.
ONCOTARGET (2017)
The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis
Min Yu et al.
ONCOTARGET (2017)
Establishing a yeast-based screening system for discovery of human GLUT5 inhibitors and activators
Joanna Tripp et al.
SCIENTIFIC REPORTS (2017)
Distribution of glucose transporters in renal diseases
Leszek Szablewski
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Emerging Biological Principles of Metastasis
Arthur W. Lambert et al.
CELL (2017)
Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment
Carly C. Barron et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides
Khyati Kapoor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Discovery of a specific inhibitor of human GLUT5 by virtual screening and in vitro transport evaluation
Alayna M. George Thompson et al.
SCIENTIFIC REPORTS (2016)
Structural Biology of the Major Facilitator Superfamily Transporters
Nieng Yan
ANNUAL REVIEW OF BIOPHYSICS, VOL 44 (2015)
In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy
Rama K. Mishra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Molecular basis of ligand recognition and transport by glucose transporters
Dong Deng et al.
NATURE (2015)
Structure and mechanism of the mammalian fructose transporter GLUT5
Norimichi Nomura et al.
NATURE (2015)
Inhibition of human GLUT1 and GLUT5 by plant carbohydrate products; insights into transport specificity
Alayna M. George Thompson et al.
SCIENTIFIC REPORTS (2015)
Crystal structure of the human glucose transporter GLUT1
Dong Deng et al.
NATURE (2014)
GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer
Mark Masin et al.
CANCER & METABOLISM (2014)
The role of fructose transporters in diseases linked to excessive fructose intake
Veronique Douard et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
The SLC2 (GLUT) family of membrane transporters
Mike Mueckler et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
William A. Flavahan et al.
NATURE NEUROSCIENCE (2013)
Structural basis for substrate transport in the GLUT-homology family of monosaccharide transporters
Esben M. Quistgaard et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
SLC2A4 gene: a promising target for pharmacogenomics of insulin resistance
Maria Lucia Correa-Giannella et al.
PHARMACOGENOMICS (2013)
Crystal structure of a glucose/H+ symporter and its mechanism of action
Cristina V. Iancu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy
Samuel K. McBrayer et al.
BLOOD (2012)
The major facilitator superfamily (MFS) revisited
Vamsee S. Reddy et al.
FEBS JOURNAL (2012)
The Role of Glucose Transporters in Brain Disease: Diabetes and Alzheimer's Disease
Kaushik Shah et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Crystal structure of a bacterial homologue of glucose transporters GLUT1-4
Linfeng Sun et al.
NATURE (2012)
Imaging hypoxia to improve radiotherapy outcome
Michael R. Horsman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Role of Monosaccharide Transport Proteins in Carbohydrate Assimilation, Distribution, Metabolism, and Homeostasis
Anthony J. Cura et al.
COMPREHENSIVE PHYSIOLOGY (2012)
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
Berislav V. Zlokovic
NATURE REVIEWS NEUROSCIENCE (2011)
Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease
Lisa Mosconi et al.
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression
Jean-Philippe Cosse et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
New and original pKa prediction method using grid molecular interaction fields
Francesca Milletti et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Hypoxia increases expression of selective facilitative glucose transporters (GLUT) and 2-deoxy-D-glucose uptake in human adipocytes
I. Stuart Wood et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): Theory and application
Massimo Baroni et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer:: Ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues
A Godoy et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Integrating virtual screening in lead discovery
TI Oprea et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2004)
Differential expression of glucose transporters in normal and pathologic thyroid tissue
K Matsuzu et al.
THYROID (2004)
Characterisation of mammalian GLUT glucose transporters in a heterologous yeast expression system
R Wieczorke et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2003)
Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival
S Baer et al.
LARYNGOSCOPE (2002)
Share Paper
